Literature DB >> 34202807

Ethnicity-Specific Normative Models of Quadruple Test as a Screening Test for Down Syndrome.

Praetip Praikaew1, Kuntharee Traisrisilp1, Chanane Wanapirak1, Ratanaporn Sekararithi1, Theera Tongsong1.   

Abstract

Background and
Objectives: To establish normative models for median levels of serum biomarkers of the second trimester quad test (alpha-fetoprotein: AFP; free beta-human gonadotropins: hCG; inhibin-A; and unconjugated estriol: uE3) specific to Thai women and to compare multiples of the median (MoMs) derived from ethnicity-specific models and those derived from Caucasian models with ethnic correction. Materials and
Methods: A cross-sectional study was undertaken in a tertiary, medical teaching center among low-risk pregnant Thai women between 14 and 21 weeks of gestation to measure the levels of the four serum biomarkers. The measured values of each biomarker were analyzed using the multivariable factorial polynomial technique for quantile regression as a function of gestational age and maternal weight.
Results: The Thai-specific normative models for the four biomarkers were generated and available for use. The MoMs of all individuals generated from our models were significantly different from conventional (Caucasian) models with ethnic correction (Wilcoxon signed-rank test; p < 0.0001 for all biomarkers). The MoMs of AFP and hCG from both methods were in agreement, but those from Thai-specific models were significantly higher. However, those of inhibin-A and uE3 were markedly different and ethnic correction was unlikely to be useful. Conclusions: The Thai-specific normative models of the quad test as a function of gestational age and maternal weight were constructed using multivariable factorial polynomial models, better than simple quantile regression or log-linear regression used in earlier decades. The analysis of MoMs supports the use of ethnicity-specific models instead of Caucasian models with ethnic correction.

Entities:  

Keywords:  Down syndrome; alpha-fetoprotein; estriol; human gonadotropins; inhibin-A; quadruple test; screening

Mesh:

Substances:

Year:  2021        PMID: 34202807     DOI: 10.3390/medicina57070651

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  8 in total

1.  Antenatal screening for Down's syndrome with the quadruple test.

Authors:  Nicholas J Wald; Wayne J Huttly; Allan K Hackshaw
Journal:  Lancet       Date:  2003-03-08       Impact factor: 79.321

2.  Performance characteristics of the UniCel DxI 800 immunoassay for the maternal serum quadruple test, including median values for each week of gestation, in Korean women.

Authors:  Jeong Hoon Lee; Yongjung Park; Borum Suh; Seon Mi Song; Oh Hun Kwon; Jeong Ho Kim
Journal:  Korean J Lab Med       Date:  2010-04

3.  Maternal weight differences do not explain ethnic differences in biochemical screening.

Authors:  P K Bryant-Greenwood; J E O'Brien; X Huang; Y Yaron; M Ayoub; M P Johnson; M I Evans
Journal:  Fetal Diagn Ther       Date:  1998 Jan-Feb       Impact factor: 2.587

4.  Strong impact of ethnicity on effectiveness of the first trimester maternal serum screen of fetal Down syndrome.

Authors:  Thitikarn Lerthiranwong; Chanane Wanapirak; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Theera Tongsong
Journal:  J Matern Fetal Neonatal Med       Date:  2017-08-02

5.  Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha-fetoprotein, hCG, and estriol.

Authors:  J E O'Brien; E Dvorin; A Drugan; M P Johnson; Y Yaron; M I Evans
Journal:  Obstet Gynecol       Date:  1997-03       Impact factor: 7.661

6.  Use of ethnic-specific medians for Hispanic patients reduces ethnic disparities in multiple marker screening.

Authors:  Luisa Wetta; Joseph Biggio; John Owen
Journal:  Prenat Diagn       Date:  2011-01-20       Impact factor: 3.050

Review 7.  Variability of adjustments to indices in determining patient risk in biochemical screening.

Authors:  K Brooks; L Chik; J E O'Brien; M Ayoub; M P Johnson; M I Evans
Journal:  Fetal Diagn Ther       Date:  1999 Jan-Feb       Impact factor: 2.587

8.  Fetal Down syndrome screening models for developing countries; Part I: Performance of Maternal Serum Screening.

Authors:  Chanane Wanapirak; Wirawit Piyamongkol; Supatra Sirichotiyakul; Fuanglada Tongprasert; Kasemsri Srisupundit; Suchaya Luewan; Kuntharee Traisrisilp; Phudit Jatavan; Theera Tongsong
Journal:  BMC Health Serv Res       Date:  2019-11-27       Impact factor: 2.655

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.